Job Requirements: M.Sc. or higher Degree in Computer Science
International Institute of Molecular and Cell Biology: Two PhD student positions in RNA bioinformatics are available in the Bujnicki group in IIMCB, Warsaw, Poland. We are looking for junior scientists with energy and passion, interested in bioinformatics, software development and biological data analysis, Poland [More]
We are seeking energetic and passionate argonauts of all stages (postdocs, graduate students, undergraduates, and research associates) to join our team. We are passionate about understanding the fundamental challenge of cancer evolution. If you are naturally curious about biology, want to invent new technologies, and enjoy working in a creative and dynamic environment, we would love to work with you! [More]
Alacris Theranostics GmbH employs next generation sequencing, bioinformatics and systems biology tools to develop personalised medicine approaches (diagnosis, treatment, pharmacological research) for cancer patients. Alacris’ strong R&D business program is focused on systems biology modelling of cancer, for prediction of disease signalling and drug action in individual patients. We work together with cancer clinics, leaders in the IT field and the pharmaceutical industry in international commercial and research projects. [More]
Your role will be to lead the effective running of the Advanced Sequencing STP for the Francis Crick Institute. You will manage a state of the art facility with cutting edge technology and technology development. Reporting to the Director of Crick Science Operations, you will manage a team of up to 10 facility staff. The post holder will work closely with scientific group leaders and the Bioinformatics and Genomics STPs to provide a highly effective sequencing service to over 100 laboratories within the Francis Crick Institute. [More]
MD Anderson is known for providing cancer patients with exceptional care, which includes early access to innovative new treatments through clinical trials. The Institute for Applied Cancer Science (IACS) is a new hybrid model that uniquely combines the drug discovery capabilities of the biopharmaceutical industry and the extensive knowledge of biology found in academia with the expertise of MD Anderson's top clinicians. IACS has the singular goal of rapidly developing novel, effective and safe therapeutics that improve patient health. IACS executes programs with the highest probability of clinical success in a rigorous, goal-oriented, data-driven manner. [More]
We are looking for a dynamic leader in computational biology to join EMBL-EBI as Head of Research. EMBL-EBI is one of the world’s leading bioinformatics institutes with around 600 staff with a focus on both computational biology research and bioinformatics service delivery. Research at EMBL-EBI comprises 8-10 dedicated research groups along with 4 further teams who combine research activities and service delivery. As Head of Research you will provide leadership for the entire EBI research portfolio – similar to a Head of Department in a University setting but without teaching and with minimal administration commitments. You will also run your own research group. This is an exciting opportunity for a successful scientist with high calibre leadership skills to provide strategic direction for EMBL-EBI’s research and have substantial influence in the broader European computational biology research area. [More]
The Senior Bioinformatics Engineers an exceptional candidate who has both deep bioinformatics experience and extensive software architecture experience. We operate at the crossroads of cancer genomics, software, and data science and are looking for that rare individual who has experience and passion for all three. Our platforms are focused on mining of cancer genomic data sets, understanding resistance to targeted therapy, matching genomic profiles to clinical trials, and identifying exceptional responders to targeted therapy. Technical and scientific challenges for the platform include data mining and visualization of large-scale cancer genomic data sets, extracting information from natural language text and building web-based data analytics platforms. [More]
Cellular differentiation refers to acquisition of specific cell-fates during development. It has become evident that this process involves genomewide reprogramming of epigenetic modifications such as histone marks resulting in transcriptional changes that drives cell-fate. Building on our expertise in epigenomics and gene regulation, we aim to investigate function of certain novel chromatin regulators and transcription factors in mediating epigenome and transcriptome reprogramming during lineage commitment and terminal differentiation. [More]
As part of our continued investment in the School of Biological Sciences (BIO) at UEA, we seek to recruit 4 talented, ambitious and dynamic lecturers. These appointments will add to thriving research areas withinBIO, and foster interdisciplinary collaborative work across the Faculty of Science, the Faculty of Health and our partner institutes on the Norwich Research Park. Successful candidates will be expected to develop an internationally competitive research programme that complements existing research strengths within the School. The specific research areas for this particular post include regulatory small RNAs, developmental biology and evolution. We particularly welcome applications from investigators with experience in analysing next-generation sequencing data (transcriptome, genome or epigenome sequencing). [More]
Moderna is seeking an exceptionally talented and highly motivated bioinformatician with a broad skill base to work as part of a highly collaborative, multi-disciplinary, and fast-paced team. Moderna s mission to develop mRNA therapeutics means that this position will be responsible for a wide range of projects, from comprehensive investigation of individual targets to efficient and concise analysis of large data sets. The successful candidate will work closely with the team to develop and apply bioinformatics tools and resources in support of numerous R&D projects and therapeutic programs. [More]